Cargando…
Gene Therapy for Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked, muscle wasting disease that affects 1 in 5000 males. Affected individuals become wheelchair bound by the age of twelve and eventually die in their third decade due to respiratory and cardiac complications. The disease is caused by mutations in the DM...
Autores principales: | Elangkovan, Nertiyan, Dickson, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673537/ https://www.ncbi.nlm.nih.gov/pubmed/34511510 http://dx.doi.org/10.3233/JND-210678 |
Ejemplares similares
-
Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023) -
Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
por: Hotta, Akitsu
Publicado: (2015) -
The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020) -
Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013) -
Duchenne Muscular Dystrophy: From Diagnosis to Therapy
por: Falzarano, Maria Sofia, et al.
Publicado: (2015)